Nabriva Therapeutics had a revenue of 2.57M in the quarter ending Jun 30, 2023, with -66.09%. This bring the company's revenue in the last twelve months to 29.39M, Increased -17.43%. In the fiscal year ending Dec 31, 2022, Nabriva Therapeutics had annual revenue of 35.67M with 31.06% growth.